Reactive treponemal test with a nonreactive RPR in a pregnant patient
A 29-year-old woman at 14 weeks' gestation has routine prenatal serology. The RPR is nonreactive. The treponemal IgG/IgM enzyme immunoassay is reactive (signal-to-cutoff 9.1) and repeats reactive; a treponemal particle agglutination test is also reactive. Records show primary syphilis 6 years ago treated with a single 2.4 million unit intramuscular dose of benzathine penicillin G, with RPR falling from 1:16 to nonreactive within 12 months and documented nonreactive results at 3 and 5 years. She has no current lesions, no rash, and no new partners in the past 2 years. She asks whether she needs 'another shot' and whether the baby is at risk.
1. Walk through the serologic algorithm and list the plausible explanations for this pattern.
Read the worked answer
Algorithm: the treponemal test was done first (reverse algorithm). A reactive treponemal result with a nonreactive RPR must be resolved with a second, different treponemal test - done here and reactive. That combination excludes a false-positive treponemal screen and means the patient has been infected with Treponema pallidum at some point.
Differential for reactive treponemal tests with a negative RPR:
- Adequately treated past infection with seroreversion of the nontreponemal test - the best fit here given the documented 1:16 → nonreactive decline and two subsequent nonreactive results.
- Very early primary syphilis before nontreponemal antibodies rise, or a prozone phenomenon (unlikely with a frankly nonreactive, rather than weakly reactive, RPR, but it must be excluded by testing a diluted sample if any suspicion exists).
- Late latent syphilis with a spontaneously negative RPR - uncommon; nontreponemal tests are usually reactive, often low titer.
- Treated infection with reinfection at a site or stage that has not yet produced a nontreponemal response.
Darkfield or PCR of a lesion would be definitive, but there is no lesion to sample.
2. Should she be treated now? Justify your decision and describe monitoring for the remainder of the pregnancy.
Read the worked answer
This is a genuine judgment call, and the reasoning should be explicit rather than reflexive.
Arguments against treatment: prior treatment was documented and stage-appropriate (single dose for primary syphilis), the nontreponemal titer seroreverted and stayed negative for years, there is no clinical evidence of reinfection, and this pattern is expected in a cured patient.
Arguments for treatment: pregnancy is the setting in which the cost of undertreating syphilis is catastrophic (stillbirth, congenital infection), some nontreponemal tests can be falsely negative, and prior treatment adequacy cannot always be independently verified. Many experts and public health programs therefore favor a dose of benzathine penicillin G 2.4 million units IM in pregnancy when prior treatment adequacy is not fully documented, and the threshold for treating is deliberately low.
Practical resolution: review the original treatment record and partner history, then decide with obstetrics and infectious disease input per local protocol; a single dose of benzathine penicillin G carries little risk, whereas missed congenital syphilis does not. Whatever is decided:
- Repeat a nontreponemal titer monthly through delivery; a rise of ≥4-fold (e.g., to 1:8 or higher) means reinfection or relapse and requires full treatment.
- Treat the partner if there is any possibility of exposure.
- Note penicillin allergy: desensitization and penicillin is the standard in pregnancy; alternatives are not considered adequate for fetal protection.
- Evaluate the neonate at delivery with physical examination and serology, since maternal IgG crosses the placenta.